Validations: Hold-Time Studies (Bulk, Intermediate & Cleaning)
Scale-Up: Extending Hold-Time Across Volumes Scale-Up: Extending Hold-Time Across Volumes Pharmaceutical manufacturing processes often utilize hold times to ensure the integrity and quality of the product throughout various steps of production. This article provides a detailed guide on extending hold times across different volumes, addressing the implications on equipment and product safety within compliance frameworks such as 21 CFR Part…
Common Sampling Plan Errors—and Fixes Introduction to Sampling Plans in Pharmaceutical Validation Sampling plans are a critical component of pharmaceutical validation, particularly in ensuring that equipment hold times, bulk hold times, and intermediate hold times are monitored effectively. Properly implemented sampling plans help maintain compliance with regulatory standards set forth by authorities such as the FDA, EMA, and MHRA, as…
Templates for Hold-Time Sampling Plans Templates for Hold-Time Sampling Plans In the pharmaceutical industry, understanding and establishing appropriate hold-time sampling plans is crucial for compliance with various regulatory requirements, including those from the US FDA, EMA, MHRA, and PIC/S. These sampling plans ensure that the biological, bulk, and intermediate hold times are maintained within acceptable limits to guarantee product quality…
Peer Review Checklists for Hold Acceptance Peer Review Checklists for Hold Acceptance The pharmaceutical industry is governed by stringent regulations to ensure product safety and efficacy. One critical aspect of ensuring compliance is the effective management of hold times for equipment and materials. This article provides a comprehensive step-by-step tutorial for pharmaceutical professionals on the use of peer review checklists…
Extending Hold-Time: What Evidence Is Enough In the pharmaceutical manufacturing environment, understanding and controlling hold times for equipment and bulk materials is crucial. This step-by-step guide is intended for pharmaceutical professionals engaged in validation activities, providing insights into extending hold times, sampling plans, acceptance criteria, and trending data to ensure compliance with the US FDA, EMA, MHRA, and PIC/S standards….
Defining Failures: OOS/OOT in Hold Studies Defining Failures: OOS/OOT in Hold Studies In the pharmaceutical industry, maintaining the integrity and quality of products during various stages of production is critical. This article provides a comprehensive step-by-step tutorial on handling Out of Specification (OOS) and Out of Trend (OOT) results in hold studies. Additionally, it discusses the regulatory requirements set forth…
Documentation of Sampling Rationale Introduction to Sampling Rationale in Pharmaceutical Validation In the pharmaceutical industry, ensuring the integrity of products throughout the manufacturing process is critical. One key component of this process is the proper documentation of sampling rationale, especially pertaining to hold-time studies of bulk and intermediate products, as well as cleaning processes. A well-structured sampling plan not only…
Attribute vs Variable Data in Acceptance Sheets In the pharmaceutical industry, adherence to cGMP standards and regulatory compliance is paramount for ensuring product quality and patient safety. Acceptance sheets play a critical role in documenting compliance during hold-time studies for various processes, including bulk and intermediate holds. This guide will explore the differences between attribute and variable data in acceptance…
Decision Trees for Re-Sampling vs Rework Decision Trees for Re-Sampling vs Rework In the pharmaceutical industry, ensuring product quality and compliance with regulatory expectations is paramount. When managing hold times of biological products, including bulk and intermediate components, the decision of whether to re-sample or rework can be critical. This step-by-step guide seeks to clarify the decision-making process through the…
Audit-Ready Sampling Storyboards Audit-Ready Sampling Storyboards Introduction to Hold-Time Studies In the pharmaceutical industry, ensuring product quality and safety during the manufacturing process is crucial. One key aspect of this process is the management of hold times for both equipment and product. Hold-time studies serve to validate the conditions under which materials can remain without compromising their safety and efficacy….